BD8-26803-35855
4 vaccinations
1 coded response
37 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 200 / DC
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Dose 1 — Moderna
-
2021-03-08
Registered in v-safe
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-17
- 2021-03-24
-
2021-03-31
Dose 2 — Moderna
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-04-02
- 2021-04-03
- 2021-04-05
- 2021-04-06
- 2021-04-09
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-06-30
- 2021-09-29
-
2021-10-25
Dose 3 — Pfizer-BioNTech
- 2021-10-29
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-08
- 2022-01-24
-
2022-04-02
Dose 4 — Pfizer-BioNTech
- 2022-04-18
- 2022-04-23
- 2022-04-30
- 2022-05-09
- 2022-05-14
- 2022-07-04
-
2022-10-01
Survey response — 6 months, dose 4MedDRA: COVID-19, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-10-04
-
2022-10-05
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Moderna | |
| 2 | 2021-03-31 | Moderna | |
| 3 | 2021-10-25 | Pfizer-BioNTech | No |
| 4 | 2022-04-02 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — 6 months, dose 4
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release